NSE · India · data to 2026-10-21
Glenmark Pharmaceuticals Ltd. (GLENMARK)
Glenmark Pharmaceuticals Ltd.: ₹2,210 on 2026-10-21. +9.8% a year since 2007, worst fall -85%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | ₹2,210 |
| Return a year since 2007 | +9.8% |
| All-time high | ₹2,515 (2026-08-28) |
| Below its high | -12.1% |
| Worst fall | -85% (2020-03-23) |
| Yearly volatility | 40% |
| Beta vs its index | 0.72 |
| Risk / reward vs its market | Low risk · High reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +8.6% |
| 2025 | +26.5% |
| 2024 | +88.4% |
| 2023 | +101.3% |
| 2022 | -19.8% |
| 2021 | +7.1% |
| 2020 | +42.0% |
| 2019 | -49.9% |
| 2018 | +16.5% |
| 2017 | -33.1% |
| 2016 | -3.6% |
| 2015 | +19.7% |
What followed its price patterns in the past
How often GLENMARK was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Volume spike on an up day | 91 | 56% | 57% | +1.9% |
| Up streak | 62 | 61% | 57% | +3.6% |
| Volume spike on a down day | 61 | 57% | 57% | +3.0% |
| Big up day | 53 | 55% | 57% | +0.9% |
| Big down day | 53 | 64% | 57% | +2.5% |
| RSI rises above 70 | 53 | 53% | 57% | +0.4% |
| Down streak | 51 | 51% | 57% | +0.0% |
| New 52-week high | 47 | 60% | 57% | +3.1% |
| Crosses above 200-day avg | 37 | 57% | 57% | +0.9% |
| Falls below 200-day avg | 36 | 69% | 57% | +4.5% |
| Squeeze breakout up | 36 | 50% | 57% | -0.1% |
| RSI drops below 30 | 35 | 51% | 57% | +0.1% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.